Citation: Cc. Mok et al., CRYPTOCOCCAL MENINGITIS PRESENTING CONCURRENTLY WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Clinical and experimental rheumatology, 16(2), 1998, pp. 169-171
Citation: Cs. Lau et al., LACK OF EVIDENCE OF ACTIVE LYTIC REPLICATION OF EPSTEIN-BARR AND CYTOMEGALOVIRUSES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Chinese medical journal, 111(7), 1998, pp. 660-665
Citation: Cc. Mok et al., TOXICITIES OF DAPSONE IN THE TREATMENT OF CUTANEOUS MANIFESTATIONS OFRHEUMATIC DISEASES, Journal of rheumatology, 25(6), 1998, pp. 1246-1247
Citation: Cc. Mok et al., ACUTE TRANSVERSE MYELOPATHY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL PRESENTATION, TREATMENT, AND OUTCOME, Journal of rheumatology, 25(3), 1998, pp. 467-473
Citation: Cc. Mok et al., RISK-FACTORS FOR AVASCULAR BONE NECROSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, British journal of rheumatology (Print), 37(8), 1998, pp. 895-900
Authors:
KARLBERG JPE
CHAN KN
FAN ST
KUNG AWC
LAUDER IJ
LOW LCK
MASAREI JRL
SULLIVAN PL
LAM SK
CHEUNG BMY
HO PC
LAM KSL
LEONG JCY
MACHIN D
NICHOLLS JM
WONG J
TSANG KWT
KUMANA CR
LAU CS
LIANG RHS
MAN RYK
OGLE CW
YEUNG CY
Citation: Jpe. Karlberg et al., ASIAN CLINICAL-TRIALS CONFERENCE 1998 - 1998 OCTOBER 25-27, HONG-KONG, CHINA, Zhongguo yaoli xuebao, 19, 1998, pp. 1-2
Authors:
LAI KC
LAM SK
HUI WM
WONG BCY
LAU CS
HU WHC
WEN ZF
Citation: Kc. Lai et al., CAN ERADICATION OF HELICOBACTER-PYLORI PREVENT FUTURE-DEVELOPMENT OF PEPTIC-ULCERS IN PATIENTS RECEIVING LONG-TERM CONTINUOUS NONSTEROIDAL ANTIINFLAMMATORY DRUGS, Gastroenterology, 114(4), 1998, pp. 787-787
Authors:
LAI KC
LAM SK
HUI WM
WONG BCY
LAU CS
HU WHC
WEN ZF
Citation: Kc. Lai et al., ERADICATION OF HELICOBACTER-PYLORI DID NOT ACCELERATE THE HEALING OF GASTRIC AND DUODENAL ULCERS EROSIONS IN PATIENTS ON LONG-TERM CONTINUOUS NONSTEROIDAL ANTIINFLAMMATORY DRUGS/, Gastroenterology, 114(4), 1998, pp. 788-788
Citation: Cc. Mok et al., ARE MALES DIFFERENT FROM FEMALES IN CLINICAL MANIFESTATIONS, DISEASE COURSE AND DAMAGE IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 193-193
Citation: Ctk. Ho et al., COMPARISON OF THE EFFICACY OF INTERMITTENT INTRAVENOUS PULSE AND CONTINUOUS ORAL CYCLOPHOSPHAMIDE IN THE TREATMENT OF DIFFUSE PROLIFERATIVENEPHRITIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 450-450
Citation: My. Mok et al., SAFETY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN RHEUMATOID-ARTHRITIS (RA) PATIENTS WITH CHRONIC VIRAL-HEPATITIS, Arthritis and rheumatism, 41(9), 1998, pp. 740-740
Citation: Cc. Mok et al., CLINICAL CHARACTERISTICS, TREATMENT AND OUTCOME OF ADULT-ONSET STILLS-DISEASE IN SOUTHERN CHINESE, Arthritis and rheumatism, 41(9), 1998, pp. 1196-1196
Citation: Cs. Lau et al., EFFECTS OF CALCITRIOL VERSUS HORMONAL REPLACEMENT THERAPY IN STEROID-INDUCED OSTEOPOROSIS IN AMENORRHEIC PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 1620-1620
Citation: Wk. Ip et al., ASSOCIATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS WITH PROMOTER POLYMORPHISMS OF THE MANNOSE-BINDING LECTIN GENE, Arthritis and rheumatism, 41(9), 1998, pp. 1663-1668
Citation: Cc. Mok et al., INTERLEUKIN-10 PROMOTER POLYMORPHISMS IN SOUTHERN CHINESE PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(6), 1998, pp. 1090-1095
Citation: Cc. Mok et al., RISK-FACTORS FOR OVARIAN FAILURE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS RECEIVING CYCLOPHOSPHAMIDE THERAPY, Arthritis and rheumatism, 41(5), 1998, pp. 831-837